Rentschler Biopharma is evolving its CDMO capabilities through strategic partnerships, infrastructure investments, and sustainability initiatives to better support clients' complex biologics programs.
Benedikt von Braunmühl
Advertisement
Articles by Benedikt von Braunmühl
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Sept. 22, 2025
2
IDT Debuts Protein Solution to Improve CRISPR Knock-In Accuracy
3
100% Pharmaceutical Tariff Will Reshape US Biopharm Manufacturing Supply Chains
4
Fresenius Kabi Contract Manufacturing Focuses on Your Success
5
